- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01317628
Effects of Tobacco Smoke Exposure on Epigenetic Signatures and Immunotoxicological Reactions
Study Overview
Status
Intervention / Treatment
Detailed Description
Teenager Smoking Reduction Trial (TSRT)
Study subjects
TSRT is a solution-oriented trial aiming to evaluate the effectiveness of tobacco smoke reduction among teenagers. Eligible teenagers will fit the following criteria: (a) age between 12 and 16 years old; (b) have active smoke habits in past 6 months; (c) amount of smoke exceed 10 cigarettes per week. The subjects will be recruited from our previous database for schoolchildren. Telephone interview will be used to screen the eligibility for the teenagers. Recruitment will occur over 3-month period from 2011 April to June. The procedure for TSRT is showed in figure 2. In this plan, we will recruit at least 31 asthmatic children and 31 non-asthmatic children who have active smoke habits.
- Data collection
A baseline data and at the 1-month and 2-month follow-up visits, the primary caregiver provided data by personal interview on parents reports. The demographic information in questionnaires included age, gender, level of education.
Teenagers will report the frequency of cigarette smoking by using a structured questionnaire. The definition of tobacco smoke exposure including: (a) ''Do you currently smoke?''-yes/no; (b) ''When did you begin to smoke regularly?''; (c) Smokers were also asked for the number of cigarettes they smoked on an average day. Nicotine dependence will be examined by using structure questionnaires from Fagerstrom model.
We will contact eligible teenagers individually to get informed consent before data collection. The effects of our teenager smoking reduction intervention program will be assessed by primary outcomes such as cotinine/creatinine ratio (CCR) and the status of tobacco smoke exposure from questionnaire. No matter which group the participant belongs to, intervention and usual control group, the secondary outcomes in all participants will be tested as follows:
- Cytokines. We will test levels of interleukin 4, 5, 13 (IL-4, 5, 13), tumor necrosis factor-α (TNF-α), interferon-gamma (INF-γ) and toll-like receptors 2, 4, 9 (TLR-2, 4, 9).
- Immunotoxicological reaction. We will determine levels of exhaled nitric oxide (eNO), serum eosinophil cationic protein (ECP) and absolute eosinophil count (AEC).
- Oxidative stress markers. Levels of the markers 8-hydroxy-2-deoxyguanosine (8-OHdG), malondialdehyde (MDA) and F2-isoprostane (Iso-P) will be examined.
After first session is applied, all participants will be tested for primary outcomes and secondary outcomes at baseline, month 1 and month 3 of the intervention process. We can then compare the biomarkers before and after the intervention program.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
(1) age between 12 and 16 years old; (2) Child had active smoking habit; and (3) have prior history of smoking habit.
Exclusion Criteria:
We will exclude children who do not fit in with the inclusion criteria.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Lifestyle counseling
Both the parents and children will receive 8 times intervention program weekly in first session.
The telephone counseling will reduce the child's tobacco smoke exposure every weekly in second session.
The interventionist and child jointly select behavioral goals for reducing tobacco smoke exposure for the child to work toward.
The goals will be formalized as a written smoke exposure reduction plan for any of four specific behaviors, as relevant to that family: (a) smoking cessation for the child, (b) making the child's primary home smoke-free, (c) making non-home locations smoke-free.
|
Both the parents and children will receive 8 times intervention program weekly in first session.
The telephone counseling will reduce the child's tobacco smoke exposure every weekly in second session.
The interventionist and child jointly select behavioral goals for reducing tobacco smoke exposure for the child to work toward.
The goals will be formalized as a written smoke exposure reduction plan for any of four specific behaviors, as relevant to that family: (a) smoking cessation for the child, (b) making the child's primary home smoke-free, (c) making non-home locations smoke-free.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in cotinine level at 3 months
Time Frame: 3 month
|
Cotinine was the major proximate metabolite of nicotine,has been widely used as a biomarker of tobacco exposure.
We will detect the urinary cotinine for children who had active smoking habit.
|
3 month
|
Change from Baseline in smoking status at 3 months
Time Frame: 3 months
|
The smoking status for children will be measure by structure questionnaire.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from Baseline in DNA methylation at 3 months
Time Frame: 3 months
|
3 months
|
Change from Baseline in immunological cytokine at 3 months
Time Frame: 3 months
|
3 months
|
Change from Baseline in miRNA expression at 3 months
Time Frame: 3 months
|
3 months
|
Change from Baseline in immunological function at 3 months
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Yungling Lee, Ph.D, National Taiwan University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 201009040R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco smoke reduction trial intervention program
-
University of RochesterNational Cancer Institute (NCI)CompletedTobacco Use Cessation | Second Hand Tobacco SmokeDominican Republic
-
Harvard School of Public Health (HSPH)National Cancer Institute (NCI); Dana-Farber Cancer Institute; HealthCore-NERI; Healis-Sekhsaria Institute for Public HealthCompleted
-
Milton S. Hershey Medical CenterCompletedTobacco UseUnited States
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedTobacco Smoke PollutionUnited States
-
University of Alabama at BirminghamUniversidade Estadual de LondrinaRecruiting
-
University of Southern DenmarkCompletedPhysical InactivityDenmark
-
Akdeniz UniversityCompletedBreast Cancer | Health Behavior | Early Detection of Cancer | Cancer Screening | Preventive Health CareTurkey
-
Vrije Universiteit BrusselUniversity of Applied Sciences and Arts of Southern Switzerland; Bern University...RecruitingChronic Low-back Pain | Overweight or ObesityBelgium, Switzerland
-
Fred Hutchinson Cancer CenterLUNGevity FoundationRecruitingLung CarcinomaUnited States
-
Odense University HospitalCompleted